Double blind placebo controlled dose ranging study of the efficacy and safety of SSR149744c [celivarone] 100 or 300mg for the prevention of ventricular arrhythmia-triggered ICD interventions.

Trial Profile

Double blind placebo controlled dose ranging study of the efficacy and safety of SSR149744c [celivarone] 100 or 300mg for the prevention of ventricular arrhythmia-triggered ICD interventions.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 May 2012

At a glance

  • Drugs Celivarone (Primary)
  • Indications Ventricular arrhythmias
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ICARIOS
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jul 2009 Actual patient number (153) added as reported by ClinicalTrials.gov
    • 02 Aug 2007 Status changed from in progress to completed.
    • 05 Oct 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top